QUOTIENT BIORESEARCH

quotient-bioresearch-logo

Quotient Bioresearch is a leading CRO, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated.

#Financial #Website #More

QUOTIENT BIORESEARCH

Social Links:

Industry:
Information Technology

Founded:
1992-01-01

Address:
Cardiff, Cardiff, United Kingdom

Country:
United Kingdom

Website Url:
http://www.quotientbioresearch.com

Total Employee:
251+

Status:
Active

Contact:
+44 (0) 1933 319900

Total Funding:
35 M GBP

Technology used in webpage:
Viewport Meta SPF Google Apps For Business Twitter Tweet Button Facebook Like Button Hubspot Forms Facebook Like Google Plus One Button LinkedIn Share Plugin Comodo SSL


Investors List

ta-associates_image

TA Associates

TA Associates investment in Private Equity Round - Quotient Bioresearch

Official Site Inspections

http://www.quotientbioresearch.com

Unable to get host informations!!!

Loading ...

More informations about "Quotient Bioresearch"

Pharmaron Acquires Quotient Bioresearch - Pharmaron

Feb 4, 2016 Pharmaron Acquires Quotient Bioresearch. To enhance service offerings and increase presence in global markets. BEIJING, February 4, 2016 โ€“ Pharmaron, a fully โ€ฆSee details»

Quotient Bioresearch - Crunchbase Company Profile & Funding

Quotient Bioresearch is a leading CRO, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated.See details»

Pharmaceutical CDMO & CRO | Quotient Sciences

Streamline your drug development outsourcing and get your therapy to patients, fast. Quotient Sciences is a trusted partner that can take your lead molecule from candidate selection, to first-in-human clinical testing, all the way through to โ€ฆSee details»

Quotient Bioresearch Company Profile 2024: Valuation, Investors ...

Quotient Bioresearch General Information Description. Operator of a contract research organization (CRO) in the life sciences sector. The company focuses on integrating โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch

Organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and development, today announced that it acquired Quotient Bioresearch (Quotient). โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch - Fierce Pharma

Feb 10, 2016 Quotient Bioresearch is a leading UK CRO based in Cardiff and Northampton, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated and โ€ฆSee details»

Quotient Bioresearch Holdings Limited | Portfolio | TA

Quotient Bioresearch was a UK-based contract research organization holding company. Quotientโ€™s various divisions provided early-stage and specialist drug development services to the global life science industry. In December 2013, โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch - Business Wire

Feb 4, 2016 Pharmaron today announced that it acquired Quotient Bioresearch. BEIJING--(BUSINESS WIRE)--Pharmaron, a fully integrated contract research organization (CRO) โ€ฆSee details»

Chinese CRO Pharmaron acquires U.K.-based Quotient โ€ฆ

Feb 11, 2016 Beijing, China-based contract research organization Pharmaron has snapped up fellow CRO Quotient Bioresearch as it looks to broaden its reach both technically and geographically.See details»

Pharmaron Acquires Quotient Bioresearch in UK - LinkedIn

Feb 4, 2016 Quotient Bioresearch is a leading UK CRO based in Cardiff and Northampton, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated and โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch - Technology Networks

Feb 12, 2016 Pharmaron has announced that it acquired Quotient Bioresearch (Quotient). Quotient, a UK-based CRO with more than 200 employees, focuses on integrating โ€ฆSee details»

LGC acquires leading bioanalytical sciences business from โ€ฆ

LGC and Quotient Bioresearch are pleased to announce that they have reached agreement on the sale by Quotient of its Bioanalytical Sciences division to LGC Quotient Bioanalytical โ€ฆSee details»

Quotient Bioresearch Celebrates Official Opening of New State-of โ€ฆ

Nov 3, 2010 Paul Cowan, Chairman & Chief Executive Officer, Quotient Bioresearch, said: โ€œWe are delighted to announce the official opening of Quotientโ€™s new state-of-the-art facility in โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch in UK - LinkedIn

Feb 11, 2016 Quotient Bioresearch is a leading UK CRO based in Cardiff and Northampton, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated and โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch | Fierce Biotech

Feb 11, 2016 Quotient Bioresearch is a leading UK CRO based in Cardiff and Northampton, providing Radiochemistry, Drug Metabolism and E-fate solutions tailored, integrated and โ€ฆSee details»

Pharmaron Acquires Quotient Bioresearch - Clinical Leader

Feb 4, 2016 Pharmaron, a fully integrated contract research organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and โ€ฆSee details»

Bioanalysis | What We Do | Quotient Sciences

Highly sensitive bioanalytical techniques enable the identification and quantification of analytes, such as small molecules, peptides, proteins, nucleic acids, and metabolites, all from very small โ€ฆSee details»

Quotient Bioresearch Investment in Bioanalytical Facility - Lab โ€ฆ

Quotient Bioresearch (โ€œQuotientโ€), the leading provider of early stage and specialist drug development services, has today announced the completion of a £1.5m expansion to its โ€ฆSee details»

Arcinova has been rebranded to Quotient Sciences

NOTTINGHAM, U.K.; July 1, 2021 โ€“ Quotient Sciences, the drug development and manufacturing accelerator, announces that it has completed the rebrand of Arcinova, the Alnwick U.K.-based โ€ฆSee details»

Quotient announces completion and publication of a RapidFACT โ€ฆ

Quotient Clinical, part of Quotient Bioresearch ("Quotient") today announced the publication of results, in the journal Pharmaceutical Research, of a RapidFACT TM program conducted for โ€ฆSee details»

linkstock.net © 2022. All rights reserved